Prof David Kaye holding up the Total Artificial Heart

News

Neurosurgery
New, minimally invasive epilepsy surgery is changing lives
7 April 2025
The Alfred is the first hospital in Victoria and the second in Australia to offer a new and highly effective kind of brain surgery to treat previously ‘inoperable’ drug-resistant epilepsy.
epilepsy
neurosurgery
patients
A/Prof Law with MRI machine
A journey through brain cancer treatment
21 May 2021
Treating brain cancer is a team effort, when a person is suspected of having a brain tumour they’ll begin their journey through treatment, starting with the first stop - Neuroradiology.  
brain
cancer
neurosurgery
oncology
pathology
patients
radiology
staff
Anthony on bicycle (L) and Anthony (R)
On the road towards a cure
11 May 2021
“When you have a brain tumour it never ends well. No one can predict how soon it might grow back. You’re dealt the hand your given, then you have to play it the best you can,” said Anthony.
bio-bank
brain
cancer
cancer research
neurosurgery
patients
A/Prof Martin Hunn with the SenTiva device
Pre-programming the way forward for epilepsy
7 April 2021
With the new model of a Vagal Nerve Stimulator (VNS), our neurology team can pre-program our epilepsy patients treatment months in advance - meaning they can visit the hospital less often.
brain
epilepsy
neurology
neurosurgery
patients
staff
Biobank brings hope for Demi
19 November 2020
This year, 22-year-old Demi Lawson has not only faced a global pandemic, but a diagnosis of brain cancer, an awake craniotomy (brain surgery) – and has been learning to live with the death of her younger brother.
brain
cancer research
neurosurgery
patients
research & innovation
Neurosurgery procedure
New hope for brain cancer treatment
28 August 2020
Making up 80 per-cent of all brain tumours in adults, gliomas such as glioblastoma (GBM) are the most common and aggressive form of brain cancer. Killing more people under forty than any other cancer, a quarter of a million people die every year from these tumours – despite current treatment options the average survival for a GBM is only 14-15 months after diagnosis
neurosurgery
research & innovation
staff